For the first time, Medicare is allowed to cover Wegovy, but only if prescribed to reduce the risk of serious cardiovascular events.

2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted

New study in Diabetes, Obesity and Metabolism reveals Brenzavvy, an affordable SGLT-2 inhibitor for type 2 diabetes, is heart-safe and effective. It lowers blood sugar...

LillyDirect, a new telehealth platform and online pharmacy, aims to improve access to resources and medication for people living with diabetes, obesity, and migraines.

Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...

CMS initiates drug price negotiations, targeting diabetes drugs among others. Resulting from the Inflation Reduction Act, it aims for cost cuts by 2026, benefiting...

Amazon Pharmacy now auto-applies coupons to insulins and other diabetes supplies. See how you can save money and time.

At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...

UnitedHealthcare begins coverage for CGM in people with type 2 diabetes.

On April 16, Medicare began covering people with type 2 diabetes for continuous glucose monitors (CGMs).

Following Eli Lilly’s recent announcement of a $35 monthly limit on out-of pocket costs, Sanofi announced a $35 cost cap on Lantus, and Novo Nordisk pledged to reduce...

Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%. The drug maker will also...

Health insurance options can be overwhelming, especially when you have a condition like diabetes. Here’s how to compare options and make sure you have the coverage you...

The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...

Under a new federal rule from the Centers for Medicare and Medicaid Services (CMS), those insured by employer health plans will now have access to significantly more...

The financial burden of managing diabetes can be overwhelming. Sanofi has updated its Valyou Savings Program to make insulin more affordable for those who are uninsured...

Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance...

US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of...

Lilly’s new basal insulin, Rezvoglar, may provide a cheaper alternative to Lantus. This marks the second approval of a biosimilar long-acting insulin.

As we approach the new year, we want to remind you that if you've met your annual health insurance deductible or are close to meeting it, do not forget to order any...